This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 228 Users Online

Vector-based RNAi Market

Vector-based RNAi Market - Global Industry Analysis 2015-2019 and Opportunity Assessment 2020 - 2030

Vector-based RNAi Market Segmented By Application Type that is Oncology, Ocular Disorders, Hepatitis B and C, Autoimmune Hepatitis, Therapeutics, Respiratory Disorders, Neurological Disorders , Other Therapeutics

Market Overview

Vector-based RNAi (RNA interference) offers a system of treatment and disease management to decrease the inhibition of gene translation or expression, as well as it neutralizes the targeted mRNA molecules. Vector-based RNAi plays very important in Cancer treatment however as per the World Health Organization, cancer is the top second cause of death across the globe and 8.8 million deaths caused due to cancer in 2015.

Whereas, worldwide nearly one in six deaths can be attributed to cancer. As well as a new development in vector-based RNAi such as small interfering RNAs (siRNA) and microRNAs (miRNA) can escalate the vector-based RNAi market growth. The challenging situation of FDA approval affecting on a number of new drugs launch, for instance, 2015 (41 drugs), while in 2016 (19 drugs) which are very less as compared with the previous year.

The major driving factor for vector-based RNAi market is growing inclination towards several applications in molecular diagnostics especially in Cancer which anticipated to drive growth. The emerging demand for vector-based RNAi is largely arising from the need for improvement in synthetic delivery carriers.

Increasing rate of cancer treatment coupled with the growing demand for chemical modifications to RNA can escalate the growth of vector-based RNAi market. Rate of morbidity and mortality across the globe increases due to incidence of Cancer consequently growth of the vector-based RNAi market will increase.

However, the decline in FDA drug approval rates due to extremely high challenges in approval for a new drug can be anticipated to restrain the growth of the vector-based RNAi market.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Market Segmentation

Application Type
  • Oncology
  • Ocular Disorders
  • Hepatitis B and C
  • Autoimmune Hepatitis
  • Therapeutics
  • Respiratory Disorders
  • Neurological Disorders
  • Other Therapeutics
End Use
  • Hospitals
  • Speciality Clinics
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Key Player

Some of the major key players competing in the global vector-based RNAi Market are Merck and Co. Inc., Phio Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Thermo Fisher Scientific Inc., Silence Therapeutics PLC, Qiagen NV, Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals, Arrowhead Pharmaceuticals, Arcturus Therapeutics and Alnylam Pharmaceuticals Associates among others.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

The report covers exhaustive analysis on:

  • Vector-based RNAi Market Segments
  • Vector-based RNAi Market Dynamics
  • Historical Actual Market Size, 2014 - 2018
  • Vector-based RNAi Market Size & Forecast 2019 to 2029
  • Vector-based RNAi Agents Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Vector-based RNAi Market Drivers and Restraints
Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

- Companies Covered in This Report -

Google translate